Elixinol Wellness Limited ELLXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.20M | 9.83M | 9.46M | 9.55M | 9.72M |
| Total Other Revenue | -15.00K | -7.60K | -400.00 | 7.10K | 14.60K |
| Total Revenue | 10.19M | 9.81M | 9.45M | 9.54M | 9.72M |
| Cost of Revenue | 6.00M | 6.06M | 6.13M | 6.25M | 6.42M |
| Gross Profit | 4.19M | 3.75M | 3.31M | 3.29M | 3.30M |
| SG&A Expenses | 5.49M | 5.69M | 5.87M | 5.75M | 5.66M |
| Depreciation & Amortization | 497.20K | 528.10K | 558.60K | 605.60K | 657.70K |
| Other Operating Expenses | -167.60K | -67.00K | 31.50K | 254.40K | 480.70K |
| Total Operating Expenses | 11.82M | 12.21M | 12.60M | 12.85M | 13.22M |
| Operating Income | -1.63M | -2.40M | -3.15M | -3.31M | -3.50M |
| Income Before Tax | -2.61M | -3.21M | -3.79M | -3.66M | -3.55M |
| Income Tax Expenses | -350.60K | -350.60K | -350.60K | -1.34M | -2.37M |
| Earnings from Continuing Operations | -2.26 | -2.86 | -3.44 | -2.32 | -1.18 |
| Earnings from Discontinued Operations | -68.80K | -82.70K | -96.40K | -96.40K | -96.40K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.33M | -2.94M | -3.54M | -2.41M | -1.28M |
| EBIT | -1.63M | -2.40M | -3.15M | -3.31M | -3.50M |
| EBITDA | -1.19M | -1.93M | -2.65M | -2.90M | -3.17M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.41B | 1.22B | 1.02B | 918.93M | 813.04M |
| Average Diluted Shares Outstanding | 1.41B | 1.22B | 1.02B | 918.93M | 813.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |